Company intelligence / Profile preview

Sygnis

Gdansk, Poland

Ownership: Private
Development stage: Other

Overview

Sygnis is a Polish deeptech company specializing in R&D and commercialization of additive manufacturing technologies—including advanced 3D bioprinters and scientific apparatus—serving industrial, academic, and healthcare sectors. The company’s products are used for rapid prototyping, research equipment provision, and supporting personalized medicine through biotechnology applications[1][2][4].

Modalities: 3D bioprintingResearch equipmentAdditive manufacturing technologies
Industry: Non-Drug Biotech

Partnerships

Membership in Silesian Nano ClusterCluster for Photonics and Fiber Opticscollaborations with Cambridge Innovation Center Warsawprojects co-financed by National Center for Research & Development (Poland)Polish Agency for Enterprise Development

Beyond the preview

Go deeper on Sygnis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sygnis.

Explore the full profile